IRIS
CALZETTA, LUIGINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 50.693
AS - Asia 8.023
EU - Europa 5.312
SA - Sud America 1.184
Continente sconosciuto - Info sul continente non disponibili 841
AF - Africa 112
OC - Oceania 24
Totale 66.189
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 50.360
SG - Singapore 3.809
CN - Cina 1.344
IT - Italia 1.133
BR - Brasile 933
RU - Federazione Russa 835
HK - Hong Kong 814
IE - Irlanda 656
VN - Vietnam 617
KR - Corea 539
UA - Ucraina 514
FR - Francia 471
DE - Germania 444
PL - Polonia 320
GB - Regno Unito 295
FI - Finlandia 232
BD - Bangladesh 220
JP - Giappone 193
CA - Canada 181
SE - Svezia 128
IN - India 115
NL - Olanda 89
ID - Indonesia 77
AR - Argentina 72
ES - Italia 48
EC - Ecuador 45
MX - Messico 43
CO - Colombia 41
IQ - Iraq 34
VE - Venezuela 32
ZA - Sudafrica 30
PK - Pakistan 29
TR - Turchia 29
AT - Austria 26
MY - Malesia 25
NG - Nigeria 25
UZ - Uzbekistan 24
BE - Belgio 23
CR - Costa Rica 23
JM - Giamaica 23
PH - Filippine 21
AU - Australia 19
CL - Cile 18
PE - Perù 16
TW - Taiwan 16
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 14
EG - Egitto 14
PT - Portogallo 14
IL - Israele 13
TH - Thailandia 13
PY - Paraguay 12
JO - Giordania 11
LT - Lituania 11
MA - Marocco 11
GR - Grecia 10
RO - Romania 10
TT - Trinidad e Tobago 10
A2 - ???statistics.table.value.countryCode.A2??? 9
IR - Iran 9
UY - Uruguay 9
PA - Panama 8
GT - Guatemala 7
HN - Honduras 7
NP - Nepal 7
SV - El Salvador 7
CI - Costa d'Avorio 6
DZ - Algeria 6
EE - Estonia 6
HU - Ungheria 6
KZ - Kazakistan 6
NI - Nicaragua 6
TN - Tunisia 6
AL - Albania 5
BG - Bulgaria 5
ET - Etiopia 5
KE - Kenya 5
KH - Cambogia 5
NZ - Nuova Zelanda 5
PR - Porto Rico 5
RS - Serbia 5
AZ - Azerbaigian 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
EU - Europa 4
MK - Macedonia 4
BA - Bosnia-Erzegovina 3
BS - Bahamas 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
OM - Oman 3
SY - Repubblica araba siriana 3
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
GA - Gabon 2
GE - Georgia 2
GY - Guiana 2
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
Totale 65.338
Salva come PNG Salva come JPEG
Città #
Wilmington 11.609
Houston 11.264
Woodbridge 10.253
Fairfield 1.945
Singapore 1.714
Ashburn 1.575
San Jose 1.134
Ann Arbor 989
Seattle 811
Hong Kong 796
Chandler 749
Cambridge 671
Dublin 567
Council Bluffs 507
Beijing 437
Medford 422
Jacksonville 356
Santa Clara 343
Dearborn 325
New York 303
Los Angeles 285
Kraków 280
Rome 258
The Dalles 247
Ho Chi Minh City 213
Lawrence 195
Dallas 181
Lauterbourg 172
Tokyo 168
Hanoi 157
Boardman 141
Moscow 139
Colorado Springs 129
Buffalo 128
Chicago 128
San Diego 121
Zhengzhou 121
Helsinki 110
São Paulo 102
Milan 99
Monte Vista 95
Menlo Park 74
Naples 74
Atlanta 66
Denver 64
London 56
Phoenix 52
Brooklyn 50
Toronto 50
Orem 49
San Francisco 47
Norwalk 46
Redondo Beach 43
North Bergen 41
Jakarta 40
Nuremberg 39
Redwood City 39
Shanghai 39
Bar Harbor 38
Montreal 37
Guangzhou 35
Warsaw 33
Columbus 30
Frankfurt am Main 30
Salt Lake City 30
Rio de Janeiro 29
Nanjing 27
Chennai 26
Hangzhou 26
Detroit 24
Hefei 24
Mountain View 24
Philadelphia 24
Verona 24
Lagos 23
Stockholm 23
Washington 23
Lappeenranta 22
Palo Alto 22
Belo Horizonte 21
Boston 21
Brasília 21
Miami 21
Brussels 20
Haiphong 20
Tashkent 20
San José 19
Charlotte 18
Elk Grove Village 18
Munich 18
Tampa 18
Da Nang 17
Guayaquil 17
Kunming 17
Mülheim 17
Poplar 17
Chengdu 16
Jinan 16
Kingston 16
Parma 16
Totale 52.066
Salva come PNG Salva come JPEG
Nome #
Impact of N-Acetylcysteine on Mucus Hypersecretion in the Airways: A Systematic Review 552
Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells 523
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis 518
Asthma and COPD in an Italian adult population: Role of BMI considering the smoking habit 517
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD 513
Interaction between corticosteroids and muscarinic antagonists in human airways 513
Glucagon-like peptide 1 receptor: A novel pharmacological target for treating human bronchial hyperresponsiveness 512
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis 511
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond 504
A Novel and Effective Balanced Intravenous-Inhalant Anaesthetic Protocol in Swine by Using Unrestricted Drugs 500
A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD 500
Optimizing drug delivery in COPD: The role of inhaler devices 500
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? 498
Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside 494
Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD 492
LABA/LAMA combination in copd: A meta-analysis on the duration of treatment 490
Asthma and comorbid medical illness. 489
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis 485
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 481
Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells 480
Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation 480
Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases 480
High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. 475
Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis 472
Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update 471
Occupational allergy to horse allergens: More than exposure to horses! 468
Pharmacological treatments in asthma-affected horses: A pair-wise and network meta-analysis 460
Umeclidinium for the treatment of chronic obstructive pulmonary disease 459
Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease 457
Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients 456
Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents? 456
Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma? 455
The prevalence of asthma and COPD in Italy: a practice-based study 454
Tiotropium formulations and safety: a network meta-analysis 454
Asthma and comorbid medical illness 453
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis 453
Can pet keeping be considered the only criterion of exposure to cat/dog allergens in the first year of life? 452
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD 451
Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study 445
Is allergic sensitization to siberian hamster preventable in high-risk individuals who are already sensitized or exposed to furry animals? 444
Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways 443
Effects of chronic treatment with the new ultra-long-acting β2-adrenoceptor agonist indacaterol alone or in combination with the β1-adrenoceptor blocker metoprolol on cardiac remodelling 443
The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils 442
The Challenges of Precision Medicine in COPD 442
Clinical effect of corticosteroids in asthma-affected horses: A quantitative synthesis 442
New Treatments for COPD in the Elderly 441
Is H1-antihistamine (desloratadine 5 mg, orodispersible tablet) premedication in NSAID-associated urticaria really safe and practicable in “real life”? 441
How many systemic reactions to skin prick tests could be preventable in defined conditions? 440
Brensocatib: Dipeptidyl peptidase 1 (DPP1) inhibitor Treatment of non-cystic fibrosis bronchiectasis 440
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi 439
Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD 439
Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi 435
Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi 434
The effect of indacaterol during an acute exacerbation of COPD 434
Dog allergen immunotherapy and allergy to furry animals 434
The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle. 432
Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? 432
Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study 431
Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi 430
Translational study searching for synergy between glycopyrronium and indacaterol 429
Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008 427
Can the presence of cat/dog at home be considered the only criterion of exposure to cat/dog allergens? A likely underestimated bias in clinical practice and in large epidemiological studies 424
The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease 423
Comorbidities of asthma 422
Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity 419
Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi 419
Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone 416
Letter to the Editor: Can dog allergen immunotherapy reduce concomitant allergic sensitization to other furry animals? A preliminary experience 416
Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis 411
Is the risk of developing atopic sensitization and bronchial asthma in animal laboratory workers preventable in well-defined susceptible individuals? 407
Critical aspects in dog allergen immunotherapy (DAI). May Component Resolved Diagnosis (CRD) play a role in predicting the efficacy? 406
What could the role of can f 5 allergen be in dog-sensitized patients in “real life”? 403
Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics 402
The clinical use of regenerative therapy in COPD 402
Combining long-acting bronchodilators with different mechanisms of action: A pharmacological approach to optimize bronchodilation of equine airways 400
Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens 399
Partial nephrectomy using radiofrequency incremental bipolar generator with multi electrode probe: experimental study in bench pig kidneys 396
Gastroesophageal reflux and COPD exacerbations: Is cholinergic-mediated oesophago-bronchial reflex a possible link? 396
Partial renal resection by LaparoNewPro: in vivo open and laparoscopic study in an animal model 396
Chronic cat allergen exposure and low sensitization: Possible limitations in patient selection? 393
Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine 389
Brain natriuretic peptide protects against hyperresponsiveness of human asthmatic airway smooth muscle via an epithelial cell-dependent mechanism 385
Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways 385
Diabetes mellitus among outpatients with COPD attending a university hospital. 384
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: An Italian Multicenter Study 383
Anaphylaxis and intimate behaviour 383
Relationship between oxytocin/vasopressin and latex in obstetric surgery: How to recognize (and prevent) allergic reactions and differentiate them from side effects? 381
Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus 376
Contribution of sensory nerves to LPS-induced hyperresponsiveness of human isolated bronchi 373
Phosphodiesterase inhibitors for chronic obstructive pulmonary disease: what does the future hold? 372
Anxiety and asthma in youth. Is a stress-induced increased cholinergic tone the possible link? 371
Brain natriuretic peptide: Much more than a biomarker 370
Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis 365
Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi 365
Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue 364
Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma 361
Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how 356
Canakinumab for the treatment of chronic obstructive pulmonary disease 355
Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi 335
Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008 334
Totale 43.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 179.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 179.663
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.563 0 0 0 31 54 186 218 76 115 203 182 498
2022/20232.109 264 148 60 236 167 537 205 126 199 14 91 62
2023/2024928 196 23 59 16 62 145 68 118 37 52 19 133
2024/20255.702 163 1.180 601 286 187 228 485 263 488 626 624 571
2025/20269.368 588 480 1.011 695 1.074 429 1.212 1.108 1.182 650 547 392
2026/20274.077 1.066 598 1.629 784 0 0 0 0 0 0 0 0
Totale 66.189